MRNA
Moderna, Inc.
73.44
+
0.95
1.31%
1 x 73.41
9 x 73.55
bid
ask
5 @ 04:00 PM
73.70+0.26 (0.35%)
Bearish
296
Bullish
580
sentiment
71.51
day range
73.60
62.55
52 week range
170.47
Prev Close72.49
Open72.73
Low71.51
High73.60
Volume2.53M
Avg. Volume3.80M
Market Cap28.23B
Inst. Own72.71%
Beta1.67
Short Ratio6.18
Div & Yield0.00 /
EPS-15.35
P/E0.00
1yr Target111.37
50day MA102.47
200day MA106.28
^DJI
Dow Jones Industrial Average
40755.80
04:45 PM
-
219.20
0.53%
^IXIC
NASDAQ Composite
17127.70
05:15 PM
+
43.40
0.25%
^GSPC
S&P 500
5503.41
04:45 PM
-
16.66
0.30%
Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
News
...
Profile
...
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Earning
...
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-08-01 | 2024-06 | -3.47 | -3.33 | 0.14 | 4.03% |
2024-05-02 | 2024-03 | -3.59 | N/A | N/A | N/A |
2024-05-02 | 2024-03 | -3.59 | -3.07 | 0.52 | 14.48% |
2024-02-22 | 2023-12 | -0.78 | N/A | N/A | N/A |
2024-02-22 | 2023-12 | -0.78 | 0.55 | 1.33 | 170.51% |
2023-11-02 | 2023-09 | -2.01 | -1.39 | 0.62 | 30.85% |
Upgrade / Downgrade
...
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-12 | Argus Research | Upgrade | Buy | Buy |
2023-08-03 | TD Cowen | Downgrade | Outperform | Market Perform |
2023-08-03 | RBC Capital | Upgrade | Outperform | Outperform |
2023-08-03 | B of A Securities | Upgrade | Neutral | Neutral |
2023-08-03 | Morgan Stanley | Upgrade | Equal-Weight | Equal-Weight |
2023-08-02 | Deutsche Bank | Downgrade | Buy | Hold |
Insider Holder
...
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-07-30 | AFEYAN NOUBAR BOGHOS | Director | 6.86M | Sale |
2022-12-27 | ANDRES JUAN | Chief Technology Officer | 12.80K | Sale |
2024-02-15 | BANCEL STEPHANE J | Chief Executive Officer | 21.08M | Sale |
2024-05-02 | BERENSON STEPHEN A. | Director | 22.20K | Conversion of Exercise of derivative security |
2023-12-05 | GARAY ARPA | Officer | 3.69K | Sale |
2024-09-02 | HOGE STEPHEN | President | 1.60M | Sale |
Institution Ownership
...
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Baillie Gifford and Company | 45.71M | 5.55B | 12.01% |
2023-06-29 | Vanguard Group Inc | 27.46M | 3.34B | 7.22% |
2023-06-29 | Blackrock Inc. | 24.16M | 2.94B | 6.35% |
2023-06-29 | State Street Corporation | 14.23M | 1.73B | 3.74% |
2023-06-29 | Flagship Pioneering Inc. | 12.89M | 1.57B | 3.39% |
2023-06-29 | Coatue Management LLC | 6.55M | 795.35M | 1.72% |
Fund Ownership
...
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 10.11M | 1.23B | 2.66% |
2023-05-30 | Vanguard International Growth Fund | 9.42M | 1.20B | 2.47% |
2023-06-29 | Vanguard 500 Index Fund | 7.81M | 948.38M | 2.05% |
2023-08-30 | Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF | 6.46M | 730.48M | 1.70% |
2023-07-30 | Vanguard Specialized-Health Care Fund | 4.45M | 523.90M | 1.17% |
2023-05-30 | Fidelity 500 Index Fund | 3.70M | 472.16M | 0.97% |
Split
...
Split | Date |
---|---|
1 : 10 | 2017-08-03 |
This topic has been deleted. Only users with topic management privileges can see it.
-
ANUBISXX = TARD
-
John Beidle = TARD
-
ANUBISXX = TARD
-
Wow Moderna has grown so much with 1 product….Just imagine what 10 more will do!!!
-
Robert Swanson = CONSPIRATARD
-
Killa = TARD
-
Factually wrong = TARD
-
David Andrew = CONSPIRATARD
-
Fucking tard!
-
Koen Weirdtard dumbfucklicus
-
David Andrew = CONSPIRATARD
-
Position Trader = TARD
-
CONSPIRATARDS galore on here!!
-
Tootsie Roll = CONSPIRATARD
-
Conspiritards
-
-
-
-
Conspiratards galore on here
-
Killa = TARD
-
Bavarian Nordic stock slides on Moderna mpox vaccine study (NASDAQ:MRNA)
news.google.com • -
Stephen Hoge Sells 318 Shares of Moderna, Inc. (NASDAQ:MRNA) Stock
news.google.com • -
Moderna Stock (MRNA) Nears a Support Level, Is It a Buy?
news.google.com • -
Smart Money Is Betting Big In MRNA Options
news.google.com • -
Moderna Inc. stock underperforms Tuesday when compared to competitors
news.google.com • -
Moderna Inc. stock underperforms Tuesday when compared to competitors
news.google.com • -
What's Going On With Moderna Stock On Tuesday?- Benzinga
news.google.com • -
Moderna’s updated COVID-19 vaccine wins U.K. approval (NASDAQ:MRNA)
news.google.com • -
MODERNA, INC. (NASDAQ: MRNA) DEADLINE ALERT: Bernstein
news.google.com • -
(MRNA) Trading Advice
news.google.com • -
Moderna's chief legal officer sells shares worth over $12k
news.google.com • -
Moderna Inc. stock underperforms Friday when compared to competitors
news.google.com •